Skip to article
Astra

Hepatology

Cirrhotic Ascites Diuretics

Use sodium restriction and spironolactone-based diuresis for uncomplicated moderate ascites, but stop or de-escalate therapy when renal, neurologic, or electrolyte toxicity emerges. Refractory ascites requires early transition to large-volume paracentesis with albumin, TIPS selection, and transplant evaluation.

Clinical question: How should physicians initiate, monitor, discontinue, and escalate diuretic therapy for ascites caused by cirrhosis?

Initial branch point

Choose diuretics by ascites severity and immediate risk

The key initial decision is whether ascites is uncomplicated and diuretic-responsive or requires drainage and escalation.

Perform diagnostic paracentesis with ascitic fluid analysis when evaluating ascites; it is a rapid, cost-effective method to establish the cause and detect ascitic fluid infection. WileyManagement of adult patients with ascites due to cirrhosisWileyManagement of adult patients with ascites due to cirrhosis - Runyon A polymorphonuclear neutrophil count of at least 250 cells/mm³ identifies spontaneous bacterial peritonitis in the absence of secondary peritonitis and shifts management away from routine outpatient diuretic titration toward infection-directed treatment and prevention of renal deterioration. NatureImpact of physical activity on clinical outcomes in patients with liver cirrhosis: a prospective observational cohort study | Scientific Reports

Grade 1 ascites, detectable only by ultrasound, requires no ascites-specific treatment. Grade 2 ascites, producing moderate symmetric abdominal distension, should be managed with sodium restriction and diuretics. Grade 3 ascites, with marked abdominal distension, should undergo complete large-volume paracentesis in a single session, followed by sodium restriction and oral diuretics unless ascites is refractory. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC

Do not treat every increase in abdominal girth as uncomplicated portal-hypertensive ascites. Infection, hepatorenal syndrome, progressive azotemia, clinically important electrolyte disturbance, or hepatic encephalopathy changes the risk-benefit balance against further diuretic escalation. These complications define diuretic-intractable ascites when they preclude effective dosing. aasldManagement of Refractory Ascites in Cirrhosis | AASLDeasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL

Ascites grade directs the initial use of diuretics and paracentesis. PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMCeasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
Clinical stateActionWhat changes the plan
Grade 1: ultrasound-only ascitesNo ascites-specific treatment. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLProgression to clinically apparent ascites warrants reassessment. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
Grade 2: moderate symmetric distensionStart sodium restriction and diuretics. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLSlow or stop escalation for renal impairment, encephalopathy, or electrolyte toxicity. aasldManagement of Refractory Ascites in Cirrhosis | AASLDeasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
Grade 3: tense or gross ascitesPerform complete large-volume paracentesis in one session, then sodium restriction and diuretics if not refractory. PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMCeasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLIf refractory, use repeated large-volume paracentesis plus albumin rather than continued ineffective diuresis. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
Refractory or diuretic-intractable ascitesUse repeated large-volume paracentesis plus albumin; assess TIPS candidacy and transplantation. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLBMJGuidelines on the management of ascites in cirrhosis - GutAvoid persistent diuretic exposure when urine sodium response is inadequate or toxicity has occurred. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL

Outpatient management

Use spironolactone and furosemide to achieve controlled net fluid loss

Titrate to clinical response without exceeding a safe daily rate of weight reduction.

For ascites requiring pharmacologic mobilization, the refractory-ascites ceiling used to judge adequate diuretic exposure is spironolactone 400 mg/day and furosemide 160 mg/day, provided those doses are tolerated; adverse effects frequently prevent reaching those maxima. aasldManagement of Refractory Ascites in Cirrhosis | AASLD Inability to mobilize ascites despite sodium restriction and maximum tolerated doses supports diuretic-resistant ascites rather than an indication for indefinite dose escalation. aasldManagement of Refractory Ascites in Cirrhosis | AASLD

Track body weight as the operational measure of diuretic intensity. During diuretic therapy, target no more than 0.5 kg/day weight loss when peripheral edema is absent and no more than 1 kg/day when edema is present. PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC Once ascites has largely resolved, reduce the regimen to the lowest effective dose rather than maintaining high-dose diuresis. PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC

Assess adherence to a sodium-restricted diet before labeling ascites diuretic-resistant. Refractory ascites is defined in part by inability to mobilize fluid despite dietary sodium restriction of 2 g/day and maximum tolerated diuretics. aasldManagement of Refractory Ascites in Cirrhosis | AASLD Rapid fluid reaccumulation after therapeutic paracentesis despite restriction also meets a refractory pattern and should prompt a procedural strategy rather than repeated medication intensification. aasldManagement of Refractory Ascites in Cirrhosis | AASLD

Diuretic response and toxicity determine whether to continue, reduce, or abandon pharmacologic fluid mobilization. PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMCeasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLaasldManagement of Refractory Ascites in Cirrhosis | AASLD
Finding during therapyInterpretationNext action
Weight loss within 0.5 kg/day without edema or 1 kg/day with edemaRate is within recommended limits. PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMCContinue clinical monitoring and adjust toward the lowest effective dose as ascites resolves. PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC
Ascites cannot be mobilized despite 2 g/day sodium restriction and maximum tolerated spironolactone 400 mg/day plus furosemide 160 mg/dayDiuretic-resistant refractory ascites. aasldManagement of Refractory Ascites in Cirrhosis | AASLDTransition to repeated large-volume paracentesis plus albumin; assess TIPS and transplantation. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLBMJGuidelines on the management of ascites in cirrhosis - Gut
Progressive azotemia, hepatic encephalopathy, or progressive electrolyte imbalanceDiuretic-intractable ascites. aasldManagement of Refractory Ascites in Cirrhosis | AASLDStop or reduce diuretics; manage the complication and use non-diuretic ascites control. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLaasldManagement of Refractory Ascites in Cirrhosis | AASLD
Urine sodium excretion not greater than 30 mmol/day on diuretics in refractory ascitesInsufficient natriuretic response to justify ongoing diuretics. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLDiscontinue diuretics and manage with paracentesis plus albumin; consider TIPS if appropriate. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL

Safety surveillance

Stop diuretics when circulatory, renal, neurologic, or sodium complications outweigh natriuresis

Monitoring is intended to identify patients in whom continued diuresis will worsen effective arterial hypovolemia or renal dysfunction.

Reassess renal function, serum sodium, clinical volume status, and encephalopathy during dose adjustment and after any acute decompensating event. Progressive azotemia, hepatic encephalopathy, and progressive electrolyte imbalance are specific diuretic-related complications that establish diuretic-intractable ascites. aasldManagement of Refractory Ascites in Cirrhosis | AASLD In refractory ascites, permanently discontinue diuretics after diuretic-induced hepatic encephalopathy, renal impairment, or electrolyte abnormalities. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL

For hypovolemic hyponatremia developing during diuretic therapy, discontinue diuretics and expand plasma volume with normal saline. PubMedGuidelines on the management of ascites in cirrhosis Restrict fluids to 1 to 1.5 L/day only in clinically hypervolemic patients with severe hyponatremia, defined as serum sodium below 125 mmol/L; routine fluid restriction is not the stated intervention for other ascites states. PubMedGuidelines on the management of ascites in cirrhosis Reserve 3% hypertonic saline for severely symptomatic acute hyponatremia and correct serum sodium slowly. PubMedGuidelines on the management of ascites in cirrhosis

Nonselective beta-blocker therapy is not automatically contraindicated by refractory ascites, but identify circulatory failure before maintaining the drug. Continue an otherwise indicated nonselective beta-blocker with close monitoring; reduce the dose or discontinue it when hypotension or acute/progressive renal dysfunction develops. PubMedGuidelines on the management of ascites in cirrhosis Earlier guidance also advises avoiding high-dose propranolol above 80 mg/day in refractory ascites. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...

Specific toxicity patterns require different immediate actions. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLPubMedGuidelines on the management of ascites in cirrhosis
ComplicationThreshold or patternImmediate diuretic action
Hypovolemic hyponatremiaOccurs during diuretic therapy. PubMedGuidelines on the management of ascites in cirrhosisDiscontinue diuretics and expand plasma volume with normal saline. PubMedGuidelines on the management of ascites in cirrhosis
Hypervolemic severe hyponatremiaSerum sodium below 125 mmol/L. PubMedGuidelines on the management of ascites in cirrhosisRestrict fluids to 1-1.5 L/day. PubMedGuidelines on the management of ascites in cirrhosis
Severely symptomatic acute hyponatremiaAcute symptoms requiring urgent sodium correction. PubMedGuidelines on the management of ascites in cirrhosisReserve 3% hypertonic saline; correct sodium slowly. PubMedGuidelines on the management of ascites in cirrhosis
Encephalopathy, renal impairment, or electrolyte abnormalities attributable to diureticsDiuretic-induced complication in refractory ascites. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLDiscontinue diuretics permanently. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL

When diuretics should not be restarted automatically

After a diuretic-induced complication, restart only if a meaningful natriuretic response is expected and treatment can be tolerated. In refractory ascites, continuation is supported only when urinary sodium excretion on treatment exceeds 30 mmol/day; otherwise, repeated large-volume paracentesis with albumin becomes the preferred fluid-control strategy. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...

Failure of diuresis

Use paracentesis with albumin first, then select TIPS and transplant pathways

Refractory ascites is a prognostic transition that should trigger procedural and transplant planning.

Refractory ascites carries poor short-term prognosis, with reported survival of 50% at 6 months and 25% at 1 year. aasldManagement of Refractory Ascites in Cirrhosis | AASLD It should therefore trigger evaluation beyond repeated outpatient diuretic changes, including candidacy for TIPS and liver transplantation. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLBMJGuidelines on the management of ascites in cirrhosis - Gut

Repeated large-volume paracentesis plus albumin at 8 g per liter of ascites removed is first-line therapy for refractory ascites. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL Large-volume paracentesis is safe and effective, with lower incidence of renal injury and electrolyte abnormalities and fewer systemic and hemodynamic disturbances than diuretics in the cited synthesis. PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC Continue using this approach when TIPS is contraindicated or deferred.

Consider TIPS for refractory ascites, recurrent ascites, very frequent need for large-volume paracentesis, or ineffective paracentesis such as loculated ascites. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL TIPS improves ascites control, but hepatic encephalopathy is an important tradeoff. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL Use caution when age exceeds 70 years, bilirubin exceeds 50 µmol/L, platelet count is below 75 × 10^9/L, MELD score is at least 18, or the patient has current hepatic encephalopathy, active infection, or hepatorenal syndrome. BMJGuidelines on the management of ascites in cirrhosis - Gut

After TIPS, continue sodium restriction and diuretics until ascites resolves, with close clinical follow-up. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ... Where TIPS is selected, small-diameter PTFE-covered stents are recommended to reduce shunt dysfunction and to reduce hepatic encephalopathy risk in patients at high risk for encephalopathy. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...

Escalation options after diuretic failure or intolerance. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLBMJGuidelines on the management of ascites in cirrhosis - GutPubMedGuidelines on the management of ascites in cirrhosis
StrategyWhen to useKey limitation or follow-up
Repeated large-volume paracentesis plus albuminFirst-line treatment for refractory ascites. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLGive albumin 8 g/L removed; repeat based on recurrence and symptoms. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
TIPSRefractory/recurrent ascites, frequent paracentesis requirement, or ineffective paracentesis from loculation. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLConsider encephalopathy risk and caution factors including MELD at least 18, active infection, or hepatorenal syndrome. BMJGuidelines on the management of ascites in cirrhosis - Guteasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL
MidodrineCase-by-case adjunct in refractory ascites. PubMedGuidelines on the management of ascites in cirrhosisA reported regimen is 7.5 mg orally three times daily with standard diuretics. PubMedKASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
Liver transplantation evaluationRefractory or recurrent ascites. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLProceed in parallel with symptom-control strategies rather than waiting for repeated diuretic failure. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL

Role of adjunctive vasoconstrictor therapy

Midodrine may be considered case by case in refractory ascites. PubMedGuidelines on the management of ascites in cirrhosis An oral dose of 7.5 mg three times daily has been reported as beneficial when added to standard diuretic therapy, but this should not substitute for paracentesis, TIPS selection, or transplant evaluation when ascites remains refractory. PubMedKASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

Longitudinal management

Reassess response after every decompensating event and avoid futile diuretic exposure

Ascites management should move promptly between diuretic-responsive and refractory pathways.

At each follow-up, document weight trajectory, peripheral edema, abdominal fluid burden, serum sodium, renal function, neurologic status, and urine sodium response when refractory ascites is being considered. A urine sodium excretion threshold above 30 mmol/day on diuretics distinguishes patients in whom maintenance diuretics may still be considered from those in whom they should be stopped. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...

When ascites has largely resolved, use the lowest effective diuretic dose and continue sodium restriction rather than preserving prior high doses. PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC When ascites recurs rapidly despite dietary restriction, medication escalation should not delay referral for serial large-volume paracentesis, TIPS assessment, and transplant evaluation. aasldManagement of Refractory Ascites in Cirrhosis | AASLDeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASL

For patients receiving nonselective beta-blockers, reassess blood pressure and kidney function concurrently with ascites therapy. Refractory ascites alone does not require beta-blocker discontinuation, but hypotension or acute/progressive renal dysfunction does. PubMedGuidelines on the management of ascites in cirrhosis

Follow-up findings that change the next ascites-management step. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMCeasl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLPubMedGuidelines on the management of ascites in cirrhosis
Follow-up findingManagement change
Ascites largely resolvedReduce diuretics to the lowest effective dose. PubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC
Urine sodium excretion greater than 30 mmol/day on diuretics in refractory ascitesMaintenance diuretics may be considered if tolerated. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
Urine sodium excretion not greater than 30 mmol/day in refractory ascitesStop diuretics and use repeated large-volume paracentesis plus albumin. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
Hypotension or acute/progressive renal dysfunction while receiving a nonselective beta-blockerReduce or discontinue the beta-blocker. PubMedGuidelines on the management of ascites in cirrhosis

References

  1. Effect of Intravenous Albumin on Renal Impairment and Mortality in ...www.nejm.org · www.nejm.org
  2. Diagnosis, prevention and treatment of hepatorenal syndrome ... - Gutgut.bmj.com · gut.bmj.com
  3. Guidelines on the management of ascites in cirrhosis - Gutgut.bmj.com · gut.bmj.com
  4. Recent advances in the prevention and treatment of decompensated ...gut.bmj.com · gut.bmj.com
  5. Trial design and end points in hepatocellular carcinoma: an EASL–AASLD–ILCA consensus statement | Nature Reviews Clinical Oncologywww.nature.com · www.nature.com
  6. Optimizing the liver transplant candidate | npj Gut and Liver - Naturewww.nature.com · www.nature.com
  7. Genetic variants of TRAF6 modulate peritoneal immunity and the risk of spontaneous bacterial peritonitis in cirrhosis: A combined prospective-retrospective study | Scientific Reportswww.nature.com · www.nature.com
  8. Impact of physical activity on clinical outcomes in patients with liver cirrhosis: a prospective observational cohort study | Scientific Reportswww.nature.com · www.nature.com
  9. Clinical Features of Refractory Ascites in Outpatientswww.sciencedirect.com · www.sciencedirect.com
  10. Management of cirrhotic ascites: Seven‐step treatment protocol ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  11. Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF) - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  12. The North American Study for the Treatment of Refractory Ascites - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  13. Ascites and Spontaneous Bacterial Peritonitis - Novel Coronavirusnovel-coronavirus.onlinelibrary.wiley.com · novel-coronavirus.onlinelibrary.wiley.com
  14. Management of adult patients with ascites due to cirrhosisonlinelibrary.wiley.com · onlinelibrary.wiley.com
  15. Spontaneous bacterial peritonitis in asymptomatic outpatients with ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  16. SHM Converge 2026 Abstracts - Society of Hospital Medicine - Wileyshmpublications.onlinelibrary.wiley.com · shmpublications.onlinelibrary.wiley.com
  17. Management of adult patients with ascites due to cirrhosis - Runyononlinelibrary.wiley.com · onlinelibrary.wiley.com
  18. Cirrhotic refractory ascites: Pathogenesis, current therapeutic strategies, and future directionswww.sciencedirect.com · www.sciencedirect.com
  19. [PDF] EASL Clinical Practice Guidelines for the management of patients ...easl.eu · easl.eu
  20. Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  21. KASL clinical practice guidelines for liver cirrhosis: Ascites and related complicationspmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  22. [PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLeasl.eu · easl.eu
  23. Management of Refractory Ascites in Cirrhosis | AASLDwww.aasld.org · www.aasld.org
  24. Guidelines on the management of ascites in cirrhosispmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov